Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1

    Contraceptive implants: friend or foe?


    Many contraceptive implant specialists provided an overview of current contraceptive implant technology and practice to the staff of the World Bank on July 18, 1995. The Director of the UNDP/UNFPA/World Health Organization/World Bank Special Program of Research, Development, and Research Training in Human Reproduction informed the audience about the history of implant technology. The chief investigator of many clinical trials of contraceptive implants in Chile discussed the mechanisms of action of implants and the benefits and disadvantages of the various types of implants that are available or under development. The only contraceptive implant on the market is Norplant, which more than 3 million women currently use. Most Norplant users live in Indonesia, followed by users in the US. Providers insert the 6 progestin-releasing rods in the upper arm, which provides protection from pregnancy for 5 years. Norplant acceptors may request removal of rods at any time. Many people are concerned that Norplant users may not have timely access to removal of the implants when they want them to be removed. Another concern is the potential for coercion since Norplant requires assistance of a medical provider to start and end use. Many women's groups in developing countries share these concerns and have protested against Norplant. As a result, developers of contraceptive implants and representatives of women's groups have met to discuss these concerns. More discussions will be needed to make sure that developers adequately address these concerns.
    Add to my documents.
  2. 2

    The Norplant solution: population control Indonesian-style.

    Helwig M

    PEOPLE'S PERSPECTIVES. 1994 Jan-Feb; (6-7):27-8.

    Massive distribution of the contraceptive implant Norplant is the focus of a UN Fund for Population Assistance-supported fertility control project in Indonesia. Although information on the project's activities is limited, there are concerns that Norplant is being used specifically to reduce the East Timor population. Depo-Provera was aggressively promoted in East Timor in a 1987 government campaign, and health care workers dispensing injections were reportedly accompanied by soldiers to enforce compliance. Occupied East Timor has the highest rates of infant and maternal mortality in Indonesia. At present, two-thirds of all Norplant implants produced worldwide are sent to Indonesia, and the national family planning program is phasing out more acceptable methods such as condoms and oral contraceptives that are under the user's control. Indonesia's birth control program has been criticized for its coercive aspects, lack of range of contraceptive options, and failure to provide women with accurate information about procedures performed as part of clinical trials.
    Add to my documents.